Despite treatment strategies in these studies did not hold anymore in the era of anti-VEGF treatment, they endorsed the heavy burden of exudative AMD even before the paradigm shift of exudative AMD treatment. The gene discussed is VEGFA; the disease is age-related macular degeneration.